Clinical Trials
5 trialsNCT02871856 2023-12-05
ILST
The University of Queensland
Phase NA Unknown
NCT03634982 2022-09-01
Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors
Revolution Medicines, Inc.
Phase 1 Unknown
NCT04697446 2021-08-10
External Control, Observational, Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patients With RET-Fusion Positive NSCLC
Blueprint Medicines Corporation
Unknown
NCT02431962 2021-03-08
Alberta Lung Cancer Screening Program
University of Calgary
Phase NA Unknown
NCT03402048 2020-11-04
EPIC
University of Turin, Italy
Phase 3 Unknown